ct-707
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2016 (NCT02695550)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Focal adhesion kinase 1INHIBITOR
PTK2 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ct-707
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06970132 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2025 | Government of China |
| NCT05580445 | Phase 1/Phase 2 (Phase 2) | Aug 11, 2022 | Government of China |
| NCT02695550 | Phase 1 | Mar 1, 2016 | Centaurus Biopharma Co., Ltd., Chinese Academy of Medical Sciences |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of China | Government | 2 | 2 | 1 | 2022 |
| Centaurus Biopharma Co., Ltd. | For profit | 1 | 1 | 1 | 2016 |
| Chinese Academy of Medical Sciences | Academic/Hospital | 1 | 0 | 1 | 2016 |
3 organizations
Page 1 / 1